Table 2.

Probiotic therapy in inflammatory bowel diseases

Model	Probiotic	Effect
Trinitrobenzene sulphonic acid or dinitrobenzene sulphonic acid	Bi. infantis	No effect
	L. acidophilus, L. casei and Bi. animalis	Reduced inflammation
	VSL#3	No effect
	Lactobacillus GG	No effect
	L. plantarum 299	No effect
	VSL#3 (DNA, subcutaneously)	Reduced inflammation
Iodoacetamide	VSL#3	Reduced inflammation
	Lactobacillus GG	Reduced inflammation
Acetic acid	L. rhamnosus GG	No effect
	L. reuteri R2LC	Reduced inflammation
	L. reuteri R2LC	Reduced inflammation
Dextran sodium sulphate	VSL#3 (irradiated and DNA*)	Reduced inflammation
IL-10 knockout mice	L. salivarius 118 (subcutaneously)	Reduced inflammation
	L. salivarius	Reduced inflammation
	Bi. infantis	Reduced inflammation
	L. plantarum 299V	Reduced inflammation
	VSL#3	Reduced inflammation
	L. salivarius	Reduced inflammation
	L. reuteri	Reduced inflammation
	VSL#3 (DNA, subcutaneously)	Reduced inflammation
E. coli-induced colitis in IL-2 knockout mice	B. vulgatus	Reduced inflammation
B. vulgatus-induced colitis	Lactobacillus GG	Prevented recurrent colitis
	L. plantarum 299V	No prevention of recurrent colitis